Literature DB >> 10235188

Familial clustering of reflux symptoms.

N J Trudgill1, K C Kapur, S A Riley.   

Abstract

OBJECTIVE: A number of case reports describe multiple family members with gastroesophageal reflux disease and Barrett' s esophagus. The wider importance of familial factors in gastroesophageal reflux disease has not been established. Therefore, we have studied the prevalence of reflux symptoms and medication use among relatives of patients with documented gastroesophageal reflux disease.
METHODS: A postal questionnaire study of the first degree relatives of six groups of matched patients. The groups comprised patients with 1) no dyspeptic symptoms; 2) reflux symptoms and a normal pH study; 3) reflux symptoms, an abnormal pH study, and a lower esophageal sphincter (LOS) pressure more than 10 mm Hg; 4) reflux symptoms, an abnormal pH study, and a LOS pressure less than 10 mm Hg; 5) Barrett's esophagus; and 6) peptic stricture.
RESULTS: Four hundred eighteen subjects replied (78% response). Infrequent reflux symptoms were equally common in all groups of relatives. Frequent reflux symptoms, however, were more common among relatives of patients with an abnormal pH study and normal (26%, p = 0.007) or low LOS pressure (27%, p = 0.01) or Barrett's esophagus (30%, p = 0.003), compared with relatives of nondyspeptic patients (9%). Frequent reflux symptoms were no more common among relatives of patients with a normal pH study (16%) or peptic stricture (18%). Reflux medication use showed a similar pattern.
CONCLUSIONS: Familial clustering of reflux symptoms is seen in relatives of patients with reflux symptoms and increased esophageal acid exposure and in relatives of patients with Barrett's esophagus.

Entities:  

Mesh:

Year:  1999        PMID: 10235188     DOI: 10.1111/j.1572-0241.1999.01060.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  19 in total

1.  Genetic influences in gastro-oesophageal reflux disease: a twin study.

Authors:  I Mohammed; L F Cherkas; S A Riley; T D Spector; N J Trudgill
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

2.  Demographic and phenotypic features of 70 families segregating Barrett's oesophagus and oesophageal adenocarcinoma.

Authors:  C M Drovdlic; K A B Goddard; A Chak; W Brock; L Chessler; J F King; J Richter; G W Falk; D K Johnston; J L Fisher; W M Grady; S Lemeshow; C Eng
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

Review 3.  Barrett esophagus: an update.

Authors:  Rami J Badreddine; Kenneth K Wang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06-01       Impact factor: 46.802

4.  Genetic risk factors for perception of symptoms in GERD: an observational cohort study.

Authors:  A Patel; S Hasak; B D Nix; G S Sayuk; R D Newberry; C P Gyawali
Journal:  Aliment Pharmacol Ther       Date:  2017-11-17       Impact factor: 8.171

5.  Prevalence of Barrett esophagus in first-degree relatives of patients with esophageal adenocarcinoma.

Authors:  Arpad Juhasz; Sumeet K Mittal; Tommy H Lee; Caishu Deng; Amitabh Chak; Henry T Lynch
Journal:  J Clin Gastroenterol       Date:  2011 Nov-Dec       Impact factor: 3.062

6.  Association between interleukin-1beta-511C/T polymorphism and reflux esophagitis in Japan.

Authors:  Atsushi Muramatsu; Takeshi Azuma; Tomoyuki Okuda; Satoko Satomi; Masahiro Ohtani; Soshoku Lee; Hiroyuki Suto; Yoshiyuki Ito; Yukinao Yamazaki; Masaru Kuriyama
Journal:  J Gastroenterol       Date:  2005-09       Impact factor: 7.527

7.  Personal and family history of cancer and the risk of Barrett's esophagus in men.

Authors:  N Khalaf; D Ramsey; J R Kramer; H B El-Serag
Journal:  Dis Esophagus       Date:  2014-02-17       Impact factor: 3.429

8.  Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults.

Authors:  A Chak; T Lee; M F Kinnard; W Brock; A Faulx; J Willis; G S Cooper; M V Sivak; K A B Goddard
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

9.  Correlation of gastroesophageal reflux disease symptoms with body mass index.

Authors:  Shamail Zafar; Israr U Haque; Ghias U N Tayyab; Ameed U Rehman; Adeel U Rehman; Nusrat U Chaudhry
Journal:  Saudi J Gastroenterol       Date:  2008-04       Impact factor: 2.485

10.  Collagen type III alpha I is a gastro-oesophageal reflux disease susceptibility gene and a male risk factor for hiatus hernia.

Authors:  B Asling; J Jirholt; P Hammond; M Knutsson; A Walentinsson; G Davidson; L Agreus; A Lehmann; M Lagerström-Fermer
Journal:  Gut       Date:  2009-04-26       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.